Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FAP |
| Upstream (Parents) |
|---|
| (<<) COL1A2 → FAP |
| Downstream (Children) |
|---|
| FAP → IL25 (>>) |
| FAP → STK17A (>>) |
| FAP → RIMS1 (>>) |
| FAP → RGS16 (>>) |
| FAP → LOX (>>) |
| FAP → TYR (>>) |
| FAP → ANGPT2 (>>) |
| FAP → DBN1 (>>) |
| FAP → LAMB1 (>>) |
| FAP → PRR16 (>>) |
| FAP → LZTS1 (>>) |
| FAP → PRR4///PRH2///PRH1 (>>) |
| FAP → RCN3 (>>) |
| FAP → CDH11 (>>) |
| FAP → PRX (>>) |
| FAP → SLC4A7 (>>) |
